1015 Capital Partners’s Colgate-Palmolive CL Stock Holding History

1015 Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.38K	Hold	26	–	–	﹤0.01%	312
2026 Q1	$2.22K	Buy	26 +7	+37%	+$624	﹤0.01%	307
2025 Q4	$1.5K	Buy	+19	New	+$1.49K	﹤0.01%	355

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

1015 Capital Partners's CL Position: Q2 2026 in Review

1015 Capital Partners held its Colgate-Palmolive (CL) position steady in Q2 2026 at 26 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

1015 Capital Partners first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,002 funds tracked by Wall St. Rank hold CL as of Q2 2026.

1015 Capital Partners held 26 shares of Colgate-Palmolive worth $2.38K as of Q2 2026.
1015 Capital Partners left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #312 holding.
1015 Capital Partners first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,002 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.